Press releases

Boston Scientific Corporation (NYSE: BSX) today announced that Ken Stein, M.D., FACC, will join the Company as Senior Vice President and Associate...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European...

The statement below is from Pete Nicholas, Chairman of the Board of Boston Scientific Corporation, on behalf of the Company, its employees and its Board of...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing final results from the landmark MADIT-CRT trial on Tuesday,...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets 9(th) Annual Focus on Health Care Conference, August 5.

Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Katharine T. Bartlett and Bruce L....

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2009, as well as guidance for net...

Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark for its LATITUDE® Patient Management system. The LATITUDE system remotely...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2009...

Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer (CEO) Jim Tobin will retire from the Company,...

Landmark trial shows Boston Scientific CRT-Ds slow the progression of heart failure in asymptomatic and mildly symptomatic patients NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wachovia 19th Annual Mid-Year Equity Conference, June 23 - 24. Jim...

Boston Scientific Corporation (NYSE: BSX) today announced that results from nine studies involving the Company's Urology/Gynecology products will...

Studies to be presented on safety and efficacy of SpyGlass System for diagnostic and therapeutic procedures throughout pancreatico-biliary system NATICK, Mass., May 28 /PRNewswire-FirstCall/ --...

SpyGlass® Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific...

Boston Scientific Corporation (NYSE: BSX) today announced that Ursula Burns and Kristina Johnson have resigned from the Company's Board of Directors...

Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...

Risk of death at five years is lower for aneurysm patients treated with coil embolization compared to surgical clipping NATICK, Mass., May 26 /PRNewswire-FirstCall/ -- Boston Scientific...

Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the ORION clinical trial, which is designed to evaluate...

Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of economic and quality of life outcomes,...

Boston Scientific Corporation (NYSE: BSX) today announced that Fitch Ratings has raised the Company's rating outlook to positive from stable, while...

Boston Scientific Corporation (NYSE: BSX) today announced positive outcomes from a substudy of patients with left main coronary...

Boston Scientific Corporation (NYSE: BSX) today announced the launch of the...

Online tools will help physicians determine treatment strategies NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray PCR Post-Op Summit in London. Jim Tobin, President and...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's events and news announcements at the annual EuroPCR...

Boston Scientific Corporation (NYSE: BSX) today announced data from its ALTITUDE Clinical Science program that show real-word survival rates for...

Analysis indicates that one life is now saved for every six patients who receive an ICD NATICK, Mass., May 14 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced...

Boston Scientific Corporation (NYSE: BSX) today announced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including...

Company's new lead system reduces implant size of the world's smallest and thinnest high-energy devices NATICK, Mass., May 12 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...

Boston Scientific Corporation today welcomed the publication of an article...

Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 30th Annual Scientific...

Data from landmark trial provide important insight for physicians in treating heart attack patients NATICK, Mass., May 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed the...

Boston Scientific Corporation is scheduled to participate in the upcoming Bank of America and Merrill Lynch Health Care Conference. Jim Tobin,...

Boston Scientific Corporation today announced financial results for the first quarter ended March 31, 2009, as well as guidance for net sales and...

Boston Scientific today announced special items that will reduce its GAAP earnings for the first quarter. The Company plans to release its first...

Boston Scientific Corporation will webcast its conference call discussing financial results for the first quarter ended March 31, 2009 on Tuesday,...

Boston Scientific Corporation announced today that the Court of Appeals for the Federal Circuit issued a decision in the Company's stent...

Boston Scientific Corporation today welcomed passage of the National Pain Care Policy Act of 2009 by the U.S. House of Representatives. The...

Boston Scientific Corporation today welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of...

Boston Scientific Corporation today announced results from an analysis of economic and quality of life outcomes, based on...

Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 58th Annual Scientific...

Boston Scientific Corporation today announced that Standard and Poor's Ratings Services has raised the Company's rating outlook to positive from...

Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the...

Boston Scientific Corporation today announced that Moody's Investors Service has raised the Company's rating outlook to stable from negative. In...

Boston Scientific Corporation is scheduled to participate in the upcoming Cowen and Company 29th Annual Health Care Conference. Jim Tobin, Chief...

Boston Scientific Corporation today welcomed approval by the U.S. House of Representative's Energy and Commerce Committee of the National Pain Care...

Boston Scientific Corporation today announced the launch of its TAXUS®...

Boston Scientific Corporation today announced that the Company's Board of Directors has elected John E. Sununu...